Osteosarcoma
General Information
(STUDY CLOSED) Phase 2 Study of Denosumab (IND#127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Pediatrics
AOST1321
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
Eligibility Information
Ineligibility Information